Previous studies have shown that the SP1 mouse mammary adenocarcinoma cell line, which is tumorigenic but nonmetastatic, acquires metastatic potential when transfected with the activated human Ha-ras gene. In addition, the process of calcium phosphate-mediated DNA transfection, as well as treatment with the calcium ionophore A23187 or with phorbol 12-myristate 13-acetate, can also result in heritable changes in the malignant behavior of SP1 cells. It was of interest, therefore, to determine whether the metastatic consequences of Ha-ras oncogene expression in SP1 cells are a primary effect of the transfected gene or whether heritable secondary changes are induced by Ha-ras oncogene expression. In the latter case, continued expression of the Ha-ras oncogene would not be required to maintain the metastatic phenotype. To test this hypothesis we introduced the Ha-ras oncogene into SP1 cells on a shuttle vector in which maintenance of the vector was dependent on selection for resistance to the antibiotic G418. Subclones which had lost the transfected Ha-ras gene were subsequently isolated following growth in nonselective medium. The Ha-ras-transfected clones and the revertant subclones were found to be equally metastatic, indicating that transfection with the Ha-ras gene does induce stable secondary changes in the metastatic phenotype of SP1 cells.Although there is a strong correlation between ras gene activation and oncogenesis (1, 2), it is not clear how this oncogene exerts its effect on the malignant phenotype. ras genes have been implicated in the initial stages of tumorigenesis as well as later stages of tumor progression, specifically metastasis. An activated Ha-ras gene can confer both tumorigenic and metastatic properties on NIH 3T3 cells (3)(4)(5)(6)(7)(8) or diploid rat embryo fibroblasts (9). Metastatic potential of many tumor cell lines is also enhanced by transfection of an activated Ha-rds oncogene (10-13). Expression of the rasencoded p21 protein is directly involved in normal cell proliferation (14), and morphological transformation by ras, and several other oncogenes, is dependent on ras gene expression (15). Many tumor cell lines, however, show no inhibition of growth when injected with anti-Ras antibodies, suggesting that additional genetic alterations render them independent of ras action (16). Evidence of "hit-and-run" tumorigenesis (17)(18)(19)(20) also suggests that secondary changes in the cellular genome are responsible for malignant transformation. Specific chromosome rearrangements are associated with Ha-ras oncogene-transformed CHEF (Chinese hamster embryo fibroblasts) cells as well as the "hit-andrun" foci recovered, following transfection with plasmid DNA alone (21). Oncogenes may, therefore, act by accelerating the frequency of genetic (or epigenetic) changes.Previous studies showed that the Ha-ras oncogene can induce metastasis of SP1 cells, which are normally tumorigenic but nonmetastatic (11), and that calcium phosphatemediated DNA transfection of SP1 cells results in the rec...